Pharmacoeconomics and Evidence-based Medicine

farmacoeconomia_investigacion_resultados_salud_outcomes10_2.jpg

Scientific and strategic consulting

We specialize in Health Outcomes Research, Health Economics and Market Access.

We work with the Pharmaceutical Industry, the Health Technology Industry and Health Professionals developing innovative scientific projects.

KNOW MORE

The 2009-2019 period in health:

We have witnessed a dizzying decade, some amazing changes.

If you look around and then think 10 years back, a number of memories come to mind. Plain phones were still the best sellers, but the smartphone war was already on.

KNOW MORE

Our company in figures

+10

YEARS’ EXPERIENCE

+10 YEARS’ EXPERIENCE

Researching and innovating in the field of health

+270

PROJECTS

+270 projects

Market access, real-world data, patient-reported outcomes, etc.

+50

CUSTOMERS

+50 PROJECTS

Pharmaceutical industry and medical devices

+40

THERAPEUTIC AREAS

+40 THERAPEUTIC AREAS

Cardiovascular and metabolic diseases, dermatology, gastroenterology, immunology, infectious diseases, nutrition, oncology, rheumatology, rare diseases...

+200

PUBLICATIONS

+200 PUBLICATIONS

Conference papers, specialized journal articles, books...

Our company

We are a scientific consultancy firm specializing in Health Outcomes Research, Health Economics and Market Access located in the Science, Technology and Business Park of Universitat Jaume I, Castellón.

Last publications

What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis

Expert consensus on a set of outcomes to assess the effectiveness of biologic treatment in psoriatic arthritis: the MERECES study

Análisis comparativo del coste de romiplostim frente a eltrombopag en pacientes con trombocitopenia inmune primaria crónica

Featured News

Our team at the annual teambuilding day

Last week, we enjoyed the annual teambuilding day. This year,...

Outcomes’10 celebrates its tenth anniversary

We are 10 years old and we celebrate it with...

We renew the corporate image

We are proud of the path we have traveled, but...